Patty Baskin
Executive Editor, Neurology®
pbaskin@aan.com
(612) 928-6021
Exam: Exam 167
Issue: February 12, 2013
Teleneurology applications: Report of the Telemedicine Work Group of the American Academy of Neurology
Upon completion of this podcast, the participant will be familiar with the opportunities for, benefits of and barriers to telemedicine that currently exist in neurology.
This program is designed for physicians who are involved in providing patient care and who wish to advance their current knowledge of clinical medicine.
Program Accreditation and Development Subcommittee (PADS) is responsible for reviewing and evaluating all CME programs. PADS members: Pradeep K. Sahota MD, FAAN, has nothing to disclose, Allison Brashear MD, FAAN, has received personal compensation for activities with Allergan, Merz, Ipsen and Osmotica as a consultant, has received personal compensation in an editorial capacity for Wemove, has received research support from Allergan, Merz, and Ipsen, J. Clay Goodman MD, FAAN, has nothing to disclose, Steven L. Lewis MD, FAAN, has received personal compensation in an editorial capacity for the journal Neurology, Barbara F. Westmoreland MD, FAAN, has nothing to disclose, Susan Rodmyre, has nothing to disclose.
Robert A. Gross, MD, PhD, FAAN has received research funding from the Department of the Army and UCBPharma. He is supported for educational endeavors from the University of Rochester Medical Center’s Clinical and Translational Science Award from the NIH. Dr. Gross has conducted clinical trials over the past five years funded by GlaxoSmithKline, UCB, Ortho-McNeil, Pfizer, and Marinus. He has served on the speakers’ bureaus for Abbott, UCB, and GlaxoSmithKline and has received consultant fees from GlaxoSmithKline and Harris Interactive. Since his appointment as Editor-in-Chief, Dr. Gross has ceased participation in industry-sponsored clinical trials and speakers’ bureaus. He receives an honorarium from AAN as Editor-in-Chief of Neurology.
Dr. Ted Burns serves as Podcast Editor for Neurology®; performs EMG studies in his neuromuscular practice (35% effort); and has received research support for consulting activities with CSL Behring and Alexion Pharmaceuticals. AAN staff members editing the test (P Baskin, L Kleffman) have no disclosures. The CME Journal Editors who have reviewed the exam are Steven Lewis, MD, who receives a stipend in his editorial capacity for Neurology and as an Associate Editor for Continuum: Lifelong Learning in Neurology; has received royalties for the books 'Field Guide to the Neurologic Examination' and 'Neurology for the Non-Neurologist;' and anticipates receiving royalties for the book 'Neurologic Disorders due to Systemic Disease;' and James WM Owens Jr. MD PhD, who receives royalties from UpToDate, Waltham, MA; grant support from NIH (PI, K08NS054882); and a stipend in his editorial capacity for Neurology.
Dr. Wechsler serves on the scientific advisory boards for Lundbeck Inc., Neurointerventions Therapeutics, Inc and Silk Road Medical, Inc; receives research support from the NIH (for patient clinical trials), provides telestroke services to hospitals in Pennsylvania and Maryland; holds stock options in Neurointerventions Therapeutics, Inc. Dr. Karam served on the editorial team for the Neurology® Resident and Fellow Section.
The other participants have nothing to disclose.
CME expires three years after publication date or sooner if podcasts are deemed out of date by reviewers.
The American Academy of Neurology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American Academy of Neurology designates that participants will receive 0.5 AMA PRA Category 1 CME credits™ by answering the multiple-choice questions in the online Podcast quiz.
The American Academy of Neurology holds copyright for all materials in this exam.
Any information regarding the identity of individuals taking the exam or their exam scores will be kept confidential.
A computer with a web browser such as Internet Explorer, Firefox, Safari, or Google Chrome is required.